FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 7118324 · Received December 14, 2017

Report

Report Number
1823260-2017-02941
Event Type
Malfunction
Date Received
December 14, 2017
Date of Event
December 2, 2017
Report Date
January 10, 2018
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Additional Manufacturer Narrative · 1

TWO VIALS OF TEST STRIP LOT 244034-11 EACH VIAL CONTAINING >10 TEST STRIPS AND THE CUSTOMER'S METER WERE RECEIVED FOR INVESTIGATION. THE TEST STRIPS AND VIAL SHOWED NO DEFECTS. THE METER APPEARED UNDAMAGED AND WAS CLEAN ON THE OUTSIDE. THE RETURNED TEST STRIPS WERE MEASURED WITH THE RETURNED METER IN COMPARISON WITH THE CURRENT MASTER LOT COAGUCHEK XS PT TEST STRIP. FOR THIS PURPOSE, TWO HUMAN BLOOD SAMPLES FROM MARCUMAR DONORS AND INTERNAL REFERENCE METERS WERE USED. MASTER LOT /RETENTION METER: MARCUMAR 3: 2.7 INR, MARCUMAR 4: 3.7 INR. CUSTOMER STRIPS/CUSTOMER METER: MARCUMAR 3: 2.7 INR (FIRST VIAL) 2.8 INR (SECOND VIAL), MARCUMAR 4: 3.7 INR (FIRST VIAL) 3.8 INR (SECOND VIAL). THE MAXIMUM DIFFERENCE BETWEEN MEASUREMENTS WITH THE SAME BLOOD SAMPLE WAS 4 %. THE RETURNED CUSTOMER MATERIAL AND RETENTION MATERIAL COMPLIED WITH SPECIFICATION.

Additional Manufacturer Narrative · 1

(B)(4). (B)(6).

Description of Event or Problem · 1

THE CUSTOMER'S MOTHER STATED THEY RECEIVED INCORRECT RESULTS FROM COAGUCHEK XS METER SERIAL NUMBER (B)(4) FOR OVER ONE YEAR. SPECIFIC DATA WAS ONLY PROVIDED FOR AN EVENT ON (B)(6) 2017. A QUESTIONABLE RESULT WAS RECEIVED FROM THE COAGUCHEK XS METER WHEN COMPARED TO THE RESULT FROM A COAGUCHEK INRANGE METER SERIAL NUMBER (B)(4) THAT WAS ON LOAN FROM A CLINIC. THE COAGUCHEK INRANGE DEVICE IS NOT SOLD IN AND IS NOT LIKE OR SIMILAR TO A DEVICE SOLD IN THE UNITED STATES. THE TESTS WERE PERFORMED DIRECTLY AFTER EACH OTHER AND BLOOD FROM ONE FINGER WAS APPLIED TO BOTH TEST STRIPS WITH A COAGUCHEK CAPILLARY TUBE. THE RESULT FROM THE COAGUCHEK XS AT 10:39 WAS (B)(6). THE RESULT FROM THE COAGUCHEK INRANGE WAS (B)(6). THERE WAS NO ALLEGATION OF AN ADVERSE EVENT. THE PATIENTS THERAPEUTIC RANGE WAS 2-3 INR. THE SUSPECT METER AND STRIPS WERE REQUESTED TO BE RETURNED FOR FURTHER INVESTIGATION. RELEVANT RETENTION TEST STRIPS (LOT 244034-10) WERE TESTED IN COMPARISON WITH THE MASTER LOT COAGUCHEK XS PT. FOR THIS PURPOSE TWO HUMAN BLOOD SAMPLES FROM (B)(6) DONORS AND (B)(6) INTERNAL REFERENCE METERS WERE USED. NO ERROR MESSAGES OCCURRED. RETENTION SAMPLES WERE ACCEPTABLE AND RETENTION MATERIAL COMPLIES WITH SPECIFICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
897478 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 24403411

Patients

Seq Age Sex Outcome Treatment
1 12 YR